Transforming growth factor-β1 induces the non-classical secretion of peroxiredoxin-I in A549 cells

Biochemical and Biophysical Research Communications

Volumn 345, Issue 1, 2006, Pages 118-123

  Chang, Jong Wook ^a   Lee, Seung Hee ^a   Lu, Yan ^a   Yoo, Yung Joon ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

A549 cells; ER Golgi independent secretory pathway; Furin; Non classical secretion; Peroxiredoxin I; TGF 1

Indexed keywords

ALPHA 1 ANTITRYPSIN; BREFELDIN A; FURIN; PEROXIREDOXIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL; CELL SECRETION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FURIN; HUMANS; LUNG NEOPLASMS; PEROXIDASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33646417688     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.073     Document Type: Article

References (41)

1. Walter P., Gilmore R., and Blobel G. Protein translocation across the endoplasmic reticulum. Cell 38 (1984) 5-8
2. Mellman I., and Warren G. The road taken: past and future foundations of membrane traffic. Cell 100 (2000) 99-112
3. Rothman J.E., and Wieland F.T. Protein sorting by transport vesicles. Science 272 (1996) 227-234
4. Nickel W. The mystery of nonclassical protein secretion: a current view on cargo proteins and potential export routs. Eur. J. Biochem. 270 (2003) 2109-2119
5. Misumi Y., Misumi Y., Miki K., Takatsuki A., Tamura G., and Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 261 (1986) 11398-11403
6. Orci L., Tagaya M., Amherdt M., Perrelet A., Donaldson J.G., Lippincott-Schwartz J., Klausner R.D., Rothman J.E., and Brefeldin A. A drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell 64 (1991) 1183-1195
7. Chae H.Z., Kim I.H., Kim K., and Rhee S.G. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268 (1993) 16815-16821
8. Wood Z.A., Schröder E., Harris J.R., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28 (2003) 32-40
9. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanism and emerging concepts in cell signaling. Free Rad. Biol. Med. 38 (2005) 1543-1552
10. Hofmann B., Hecht H.J., and Flohe L. Peroxiredoxins. Biol. Chem. 383 (2002) 347-364
11. Georgiou G., and Masip L. An overoxidation journey with a return ticket. Science 300 (2003) 592-594
12. Wood Z.A., Poole L.B., and Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003) 650-653
13. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., and van Etten R.A. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defense and tumor suppression. Nature 424 (2003) 561-565
14. Okado-Matsumoto A., Matsumoto A., Fujii J., and Taniguchi N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J. Biochem. (Tokyo) 127 (2000) 493-501
15. Chang J.W., Jeon H.B., Lee J.H., Yoo J.S., Chun J.S., Kim J.H., and Yoo Y.J. Augmented expression of peroxiredoxin-I in lung cancer. Biochem. Biophys. Res. Commun. 289 (2001) 507-512
16. Chang J.W., Lee S.H., Jeoung J.Y., Chae H.Z., Kim Y.C., Park Z.Y., and Yoo Y.J. Preoxiredoxin-1 is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett. 579 (2005) 2873-2877
17. Dubois C.M., Laprise M., Blanchette F., Gentry L.E., and Leduc R. Processing of transforming growth factor β1 precursor by human furin convertase. J. Biol. Chem. 270 (1995) 10618-10624
18. Dubois C.M., Blanchette F., Laprise M., Leduc R., Grondin F., and Seidah N.G. Evidence that furin is an authentic transforming growth factor-β1-converting enzyme. Am. J. Pathol. 158 (2001) 305-316
19. Kong F.M., Washington M.K., Jirtle R.L., and Anscher M.S. Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotheraphy: a possible tumor marker. Lung Cancer 16 (1996) 47-59
20. Barthelemy-Brichant N., David J.L., Bosquee L., Bury T., Seidel L., Albert A., Bartsch P., Baugnet-Mahieu L., and Deneufbourg J.M. Increased TGF-β1 plasma level in patients with lung cancer: potential mechanisms. Eur. J. Clin. Invest. 32 (2002) 193-198
21. Yanagawa H., Sone S., Takahashi Y., Haku T., Yano S., Shinohara T., and Ogura T. Serum levels of interleukin 6 in patients with lung cancer. Br. J. Cancer 71 (1995) 1095-1098
22. Martin G., Santolaria F., Batista N., Milena A., Gonzalez-Reimers E., Brito M.J., and Ornamas J. Cytokine levels (IL-6 and IFN-γ), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11 (1999) 80-86
23. Jean F., Stella K., Thomas L., Liu G., Xiang Y., Reason A.J., and Thomas G. α1-antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc. Natl. Acad. Sci. USA 95 (1998) 7293-7298
24. Rubartelli A., Cozzolino F., Talio M., and Sitia R. A novel secretory pathway for interleukin-1β, a protein lacking a signal sequence. EMBO J. 9 (1990) 1503-1510
25. Cooper D.N.W., and Barondes S.H. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell Biol. 110 (1990) 1681-1691
26. Prudovsky I., Mandinova A., Soldi R., Bagala C., Graziani I., Landriscina M., Tarantini F., Duarte M., Bellum S., Doherty H., and Maciag T. The non-classical export routs: FGF1 and IL-1α point the way. J. Cell Sci. 116 (2003) 4871-4881
27. Schäfer T., Zentgraf H., Zehe C., Brügger B., Bernhagen J., and Nickel W. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279 (2004) 6244-6251
28. Flieger O., Engling A., Bucala R., Lue H., Nickel W., and Bernhagen J. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 551 (2003) 78-86
29. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Repots 3 (2002) 995-1001
30. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., and Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. ADIS 11 (1997) 1421-1431
31. Elliott G., and O'Hare P. Intracellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 (1997) 223-233
32. Denny P.W., Gokoo S., Russe D.G., Field M.C., and Smith D.F. Acylation-dependent protein export in Leishmania. J. Biol. Chem. 275 (2000) 11017-11025
33. Lafon-Cazal M., Adjali O., Galéotti N., Poncet J., Jouin P., Homburger V., Bockaert J., and Marin P. Proteomics analysis of astrocytic secretion in the mouse. J. Biol. Chem. 278 (2003) 24438-24448
34. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1473 (1999) 172-185
35. Jackson A., Friedman S., Zhan X., Engleka K.A., Forough R., and Maciag T. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 89 (1992) 10691-10695
36. Derynck R., Akhurst J.R.J., and Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29 (2001) 117-129
37. Hasegawa Y., Takanashi S., Kanehira Y., Tsushima T., Iami T., and Okumura K. Transforming growth factor-β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91 (2001) 964-971
38. Donnelly S., O'Neill S.M., Sekiya M., Mulcahy G., and Dalton J.P. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect. Immun. 73 (2005) 166-173
39. Bassi D.E., Fu J., de Cicco R.L., and Klein-Szanto A.J.P. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinog. 44 (2005) 151-161
40. Rubartelli A., Bajetto A., Allavena G., Wollman E., and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267 (1992) 24161-24164
41. Kinnula V.L., Pääkko P., and Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett. 569 (2004) 1-6